Ordinary shares

The company’s shares are listed on the London Stock Exchange.

Registrar
The company’s share register is administered by Lloyds TSB Registrars, who also provide the following services:

• GlaxoSmithKline Investment Plan
The plan enables shareholders to reinvest quarterly dividends and/or make monthly investments in the company’s ordinary shares using a special dealing arrangement.

• GlaxoSmithKline Individual Savings Account
The GlaxoSmithKline Individual Savings Account (ISA) is a tax-efficient way to invest in the company’s ordinary shares.

• GlaxoSmithKline Corporate Sponsored Nominee
The corporate sponsored nominee provides a facility for shareholders to hold shares without the need for share certificates. Shareholders’ details will not be held on the main share register, and so will remain confidential.

• www.shareview.co.uk
The shareview portfolio service provides shareholders with information on their investment in the company. Shareholders may register for this service at www.shareview.co.uk.

Share dealing facility
NatWest Stockbrokers Limited offer a share-dealing service on behalf of the company to shareholders wishing to buy or sell the company’s shares.

Share price information
Share price information is available on the company’s website at www.gsk.com. Information is also available on Ceefax, Teletext, and from FT Cityline by calling 0906 003 5694 or 0906 843 5694 (calls charged at 60p a minute at all times).

American Depositary Shares

The company’s shares are listed on the New York Stock Exchange in the form of American Depositary Shares (ADSs) and these are evidenced by American Depositary Receipts (ADRs), each one of which represents two ordinary shares.

ADR programme administrator
The ADR programme is administered by The Bank of New York, who also provide the following service:

• Global BuyDIRECT
Global BuyDIRECT is a direct ADS purchase/sale and dividend reinvestment plan for ADR holders.

SmithKline Beecham plc Floating Rate Unsecured Loan Stock 1990/2010

The loan stock is not listed on any exchange but holders may choose to have it redeemed by SmithKline Beecham plc at par, i.e. £1 for every £1 of loan stock held, on the first business day of March, June, September and December. Holders wishing to redeem all or part of their Loan Stock should complete the notice on the back of their loan stock certificate and return it to the registrar, to arrive at least 30 days before the relevant redemption date.

The Queen Elizabeth II Conference Centre,	21st May 2001
Broad Sanctuary, Westminster, London SW1P 3EE

The AGM is the company’s principal forum for communication with private shareholders. In addition to the formal resolutions to be put to the meeting, there will be a presentation by the Chief Executive Officer on the performance of the business and its future development. There will be opportunity for questions to the Board, and the Chairmen of the Board’s committees will take questions on matters relating to those committees.

Investors holding shares in the company through a nominee service should arrange with that nominee service to be appointed a proxy in respect of their shareholding in order to attend and vote at the meeting. ADR holders wishing to attend the meeting must obtain a proxy from the Bank of New York which will enable them to attend the meeting and vote on the business to be transacted. ADR holders may instruct The Bank of New York as to how the ordinary shares represented by their ADRs should be voted by completing and returning the voting card provided by The Bank of New York in accordance with the instructions given.

Financial reporting

Announcement of 1st Quarter Results	24th April 2001
Announcement of 2nd Quarter Results	24th July 2001
Publication of Half-Year Review	August 2001
Announcement of 3rd Quarter Results	23rd October 2001
Preliminary Announcement of Annual Results	14th February 2002
Publication of Annual Report/Review	March 2002

Results announcements
The results announcements are issued to the London Stock Exchange (LSE), and made available on the LSE news service. At the same time, or shortly afterwards, they are issued to the media, are made available on the company’s website and are filed in the USA with the Securities Exchange Commission (SEC) and the New York Stock Exchange.

Financial reports
The company publishes an Annual Report and, for the investor not needing the full detail of the Report, an Annual Review. An interim Report and Review are published at the half-year.

The financial reports are posted out to shareholders on the date of publication and are available from the same date on the company’s website. Shareholders are provided with the Annual Review and may elect to receive also the Annual Report.

Copies in printed form of the most recent, and previous, financial reports are available in the UK from the company’s registrar and in the USA from the company’s Customer Response Center.

Publications

The Environmental, Health & Safety Review 2000 is available from the Secretariat at the company’s head office.

Back to top